Richard Buchholz Purchases 1,000 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) Director Richard Buchholz purchased 1,000 shares of the company’s stock in a transaction on Friday, March 13th. The shares were purchased at an average cost of $14.84 per share, for a total transaction of $14,840.00. Following the completion of the transaction, the director directly owned 13,666 shares of the company’s stock, valued at approximately $202,803.44. This represents a 7.90% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Shoulder Innovations Stock Performance

Shares of SI opened at $15.18 on Thursday. The company has a market cap of $313.36 million and a PE ratio of -0.07. The firm has a 50-day moving average of $13.77 and a 200-day moving average of $13.86. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $17.94. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.07 and a quick ratio of 9.55.

Shoulder Innovations (NYSE:SI) last issued its earnings results on Tuesday, March 10th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.04. Shoulder Innovations had a negative net margin of 85.29% and a negative return on equity of 37.68%. The company had revenue of $14.42 million for the quarter, compared to analysts’ expectations of $12.69 million. As a group, equities analysts forecast that Shoulder Innovations, Inc. will post -0.56 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. The Goldman Sachs Group reissued a “buy” rating on shares of Shoulder Innovations in a report on Friday, January 9th. Weiss Ratings reaffirmed a “sell (e)” rating on shares of Shoulder Innovations in a report on Monday, December 29th. Morgan Stanley upped their price objective on shares of Shoulder Innovations from $18.00 to $23.00 and gave the company an “overweight” rating in a report on Tuesday, December 2nd. Finally, BTIG Research increased their price objective on shares of Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, March 11th. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and an average price target of $20.80.

Institutional Investors Weigh In On Shoulder Innovations

A number of institutional investors have recently made changes to their positions in the company. Millennium Management LLC bought a new position in shares of Shoulder Innovations during the fourth quarter worth approximately $1,316,000. Walleye Capital LLC lifted its holdings in Shoulder Innovations by 30.1% during the 4th quarter. Walleye Capital LLC now owns 93,434 shares of the company’s stock worth $1,336,000 after purchasing an additional 21,619 shares during the last quarter. State Street Corp boosted its stake in Shoulder Innovations by 50.6% in the 4th quarter. State Street Corp now owns 58,422 shares of the company’s stock valued at $835,000 after purchasing an additional 19,641 shares during the period. Wells Fargo & Company MN grew its holdings in Shoulder Innovations by 66.3% in the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock valued at $75,000 after buying an additional 2,094 shares in the last quarter. Finally, Jane Street Group LLC acquired a new position in Shoulder Innovations in the 4th quarter valued at $234,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.